Two Decades of Work, Challenges Behind Breakthrough Cancer Treatment


January 29, 2013

Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine and director of Translational Research in the Abramson Cancer Center, and David Porter, MD, a professor in the Division of Hematology-Oncology and director of Blood and Marrow Transplantation in the Abramson Cancer Center, are featured in anAAMC Reporter article detailing the evolution of their research using gene therapy to treat leukemia. The piece details the long process of conducting laboratory experiments and securing funding necessary to move the work into clinical trials, noting the importance of support from foundations such as the Leukemia and Lymphoma Society and the Alliance for Cancer Gene Therapy.

AAMC Reporter article